Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8171)
All Articles published online
|
Publishing Process of This Article
|
Jan 14, 2013 (publication date) through Jun 4, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sherid M, Sifuentes H, Samo S, Deepak P, Sridhar S. Lubiprostone induced ischemic colitis. World J Gastroenterol 2013; 19(2): 299-303 [PMID: 23345954 DOI: 10.3748/wjg.v19.i2.299] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i2/299.htm |
| Number | Citing Articles |
| 1 |
Jie An, Kaiqi Wu, Teng Wu, Pengyang Xu, Chuanli Yang, Yunhe Fan, Qing Li, Xiushan Dong. Assessing the association between drug use and ischaemic colitis: a retrospective pharmacovigilance study using FDA Adverse Event data. BMJ Open 2025; 15(5): e088512 doi: 10.1136/bmjopen-2024-088512
|
| 2 |
Lubiprostone for chronic constipation in adults. Drug and Therapeutics Bulletin 2014; 52(4): 42 doi: 10.1136/dtb.2014.4.0246
|
| 3 |
Muhammed Sherid, Humberto Sifuentes, Salih Samo, Samian Sulaiman, Husein Husein, Ruth Tupper, Charles Spurr, John Vainder, Subbaramiah Sridhar. Risk Factors of Recurrent Ischemic Colitis: A Multicenter Retrospective Study. The Korean Journal of Gastroenterology 2014; 63(5): 283 doi: 10.4166/kjg.2014.63.5.283
|
| 4 |
Lawrence J Brandt, Paul Feuerstadt, George F Longstreth, Scott J Boley. ACG Clinical Guideline: Epidemiology, Risk Factors, Patterns of Presentation, Diagnosis, and Management of Colon Ischemia (CI). American Journal of Gastroenterology 2015; 110(1): 18 doi: 10.1038/ajg.2014.395
|
| 5 |
Muhammed Sherid, Humberto Sifuentes, Salih Samo, Samian Sulaiman, Husein Husein, Ruth Tupper, Sankara N Sethuraman, Charles Spurr, John A Vainder, Subbaramiah Sridhar. Ischemic colitis: A forgotten entity. Results of a retrospective study in 118 patients. Journal of Digestive Diseases 2014; 15(11): 606 doi: 10.1111/1751-2980.12182
|
| 6 |
Nicholas Wilson, Ron Schey. Lubiprostone in constipation: clinical evidence and place in therapy. Therapeutic Advances in Chronic Disease 2015; 6(2): 40 doi: 10.1177/2040622314567678
|
| 7 |
Corrado Blandizzi, Carmelo Scarpignato. A worldwide yearly survey of new data in adverse drug reactions. Side Effects of Drugs Annual 2014; 36: 539 doi: 10.1016/B978-0-444-63407-8.00036-8
|
| 8 |
Hong Yang, Tonghui Ma. Luminally Acting Agents for Constipation Treatment: A Review Based on Literatures and Patents. Frontiers in Pharmacology 2017; 8 doi: 10.3389/fphar.2017.00418
|
| 9 |
Chris Shamatutu, Daljeet Chahal, Isabella T. Tai, Peter Kwan, Hirotada Akiho. Ischemic Colitis after Colonoscopy with Bisacodyl Bowel Preparation: A Report of Two Cases. Case Reports in Gastrointestinal Medicine 2020; 2020: 1 doi: 10.1155/2020/8886817
|
| 10 |
|
| 11 |
Sam Maher, Caroline Geoghegan, David J. Brayden. Safety of surfactant excipients in oral drug formulations. Advanced Drug Delivery Reviews 2023; 202: 115086 doi: 10.1016/j.addr.2023.115086
|
| 12 |
Muhammed Sherid, Salih Samo, Samian Sulaiman, Husein Husein, Sankara N. Sethuraman, John A. Vainder. Is CT Angiogram of the Abdominal Vessels Needed following the Diagnosis of Ischemic Colitis? A Multicenter Community Study. ISRN Gastroenterology 2014; 2014: 1 doi: 10.1155/2014/756926
|
| 13 |
Shilan Mozaffari, Shekoufeh Nikfar, Mohammad Abdollahi. The safety of novel drugs used to treat irritable bowel syndrome. Expert Opinion on Drug Safety 2014; 13(5): 625 doi: 10.1517/14740338.2014.902932
|
| 14 |
Christopher Anton, Colin Crawford. Adverse effects of laxatives: update. Adverse Drug Reaction Bulletin 2017; 303(1): 1171 doi: 10.1097/FAD.0000000000000023
|
| 15 |
Supriya Rao, H. Christian Weber. New treatment targets for the management of irritable bowel syndrome. Current Opinion in Endocrinology, Diabetes & Obesity 2014; 21(1): 9 doi: 10.1097/MED.0000000000000034
|
| 16 |
Emanuel Raschi, Fabrizio De Ponti. Lubiprostone: pharmacokinetic, pharmacodynamic, safety and regulatory aspects in the treatment of constipation-predominant irritable bowel syndrome. Expert Opinion on Drug Metabolism & Toxicology 2014; 10(2): 293 doi: 10.1517/17425255.2013.876410
|
| 17 |
Fan Li, Tao Fu, Wei-Dong Tong, Bao-Hua Liu, Chun-Xue Li, Yu Gao, Jin-Song Wu, Xiang-Feng Wang, An-Ping Zhang. Lubiprostone Is Effective in the Treatment of Chronic Idiopathic Constipation and Irritable Bowel Syndrome. Mayo Clinic Proceedings 2016; 91(4): 456 doi: 10.1016/j.mayocp.2016.01.015
|
| 18 |
Qingqing Li, Jijun Zhang, Chuanli Yang, Xiushan Dong, Yan Wang. Evaluation of post-market adverse events of lubiprostone: a real-world adverse event analysis from the FAERS database. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-03987-9
|